The role of COPD in development of osteoporosis

I. Zhila, N. Shaporova, O. Zhila, O. Galkina, E. Bogdanova (Saint Petersburg, Russian Federation)

Source: International Congress 2014 – Markers
Session: Markers
Session type: Thematic Poster Session
Number: 562
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Zhila, N. Shaporova, O. Zhila, O. Galkina, E. Bogdanova (Saint Petersburg, Russian Federation). The role of COPD in development of osteoporosis. Eur Respir J 2014; 44: Suppl. 58, 562

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014


The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014



Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014

Metabolic syndrome in patients with COPD
Source: International Congress 2014 – Clinical presentations
Year: 2014

Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Mortality predictors in stable COPD
Source: International Congress 2014 – Predictors
Year: 2014


Is clinical presentation different between men and women with COPD?
Source: International Congress 2014 – Clinical presentations
Year: 2014


Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Characteristics of essential hypertension in COPD patients
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014

Comorbidity at COPD - is actual problem of pulmonology
Source: International Congress 2014 – Predictors
Year: 2014


Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


A multimarker approach to identify atherosclerosis in COPD
Source: International Congress 2014 – Markers
Year: 2014

Mukoregulatory drugs in treating COPD
Source: International Congress 2014 – Predictors
Year: 2014


COPD on anti-GERD therapy remains at higher risk for severe exacerbation
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Inter-relationship of different types of respiratory symptoms in COPD
Source: International Congress 2014 – Comorbidities
Year: 2014

Adrenomedullin optimizes mortality prediction in COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014


Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014